Webinar | Biosimilars 2022 Year in Review

Fish & Richardson
Contact
Since the passage of the Biologics Price Competition and Innovation Act (BPCIA), the field of biosimilars has expanded and evolved. Keeping abreast of these changes helps stakeholders understand future opportunities.

In this webinar, life sciences attorneys Geoff Biegler and Jenny Shmuel will provide a comprehensive look at the U.S. biosimilars field in 2022. The webinar will cover:

- The U.S. biosimilars market, including approvals and launches

- See more +

Since the passage of the Biologics Price Competition and Innovation Act (BPCIA), the field of biosimilars has expanded and evolved. Keeping abreast of these changes helps stakeholders understand future opportunities.

In this webinar, life sciences attorneys Geoff Biegler and Jenny Shmuel will provide a comprehensive look at the U.S. biosimilars field in 2022. The webinar will cover:

- The U.S. biosimilars market, including approvals and launches

- Legislative and regulatory developments

- Litigation and post-grant trends

- Additionally, our hosts will discuss other developments they anticipate in the biosimilars space in the coming year. See less -

Embed
Copy

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Fish & Richardson | Attorney Advertising

Written by:

Fish & Richardson
Contact
more
less

Fish & Richardson on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide